Product Overview
Tesamorelin HA is a synthetic peptide analog of human growth hormone-releasing hormone (GHRH), consisting of 44 amino acids with a trans-3-hexenoic acid modification at the N-terminus. This modification enhances its stability and half-life compared to natural GHRH. Tesamorelin HA is primarily studied for its potential to stimulate endogenous growth hormone (GH) secretion, which may influence body composition and metabolic processes.
- Molecular Formula: C221H366N72O67S
- Molecular Weight: 5135.9 g/mol
- Sequence: trans-3-hexenoic acid-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2
- Available Sizes: 5mg, 10mg
- Purity Grades: Lyophilized 99%+, Lyophilized 98.5%+, Non-Lyophilized 98.5%+
- Form: Lyophilized or Non-Lyophilized Powder
Our Tesamorelin HA products undergo rigorous third-party testing to ensure the highest purity and quality standards. Certificates of Analysis (COA) are available upon request and include detailed information on:
- Purity Levels
- Peptide Sequence Verification
- Contaminant Screening
- Batch Numbers
- Testing Dates
To request a COA for your specific batch, please contact our customer support team with your order details.
Tesamorelin has been extensively studied for its effects on body composition and metabolic parameters. Key research findings include:
- Reduction of Visceral Fat: Clinical trials have demonstrated that Tesamorelin can significantly reduce visceral adipose tissue in individuals with HIV-associated lipodystrophy. [Study]
- Improved Metabolic Parameters: Tesamorelin treatment has been associated with improvements in lipid profiles and reductions in liver fat content. [Study]
- Mechanism of Action: Tesamorelin stimulates the pituitary gland to release endogenous growth hormone, which in turn increases insulin-like growth factor 1 (IGF-1) levels, influencing various metabolic processes. [Source]
What is Tesamorelin HA?
Tesamorelin HA is a synthetic analog of human growth hormone-releasing hormone (GHRH), modified to enhance stability and half-life. It is primarily used in research settings to study its effects on growth hormone secretion and metabolic processes.
How does Tesamorelin HA work?
Tesamorelin HA binds to GHRH receptors in the pituitary gland, stimulating the release of endogenous growth hormone. This increase in growth hormone can influence body composition, lipid metabolism, and other physiological processes.
Is Tesamorelin HA safe?
As a research compound, Tesamorelin HA is intended for laboratory research purposes only. Safety profiles are based on clinical studies, and it should not be used for human consumption.
Do I need a prescription for Tesamorelin HA?
No, Tesamorelin HA is sold for research purposes only and is not intended for human use. A prescription is not required for purchase.
This product is sold as a pure compound for research purposes only and is not intended for use as a dietary supplement. Please refer to our terms and conditions prior to purchase.
Safety Information: Keep this product out of the reach of children. This material has limited research available and may result in adverse effects if improperly handled or consumed. This product is not a dietary supplement but a pure substance, sold as a raw material. We attest exclusively to the quality, purity, and description of the materials we provide. This product is for use and handling only by persons with the knowledge and equipment to safely handle this material.